
KYOTO -- A team led by Japanese biotech venture AnGes will ready production capacity for 1 million doses of coronavirus vaccines by March, a fivefold increase from the original plan, in order to ensure swift access to the domestic population.
AnGes-led team ramps up capacity while product is still under development
KYOTO -- A team led by Japanese biotech venture AnGes will ready production capacity for 1 million doses of coronavirus vaccines by March, a fivefold increase from the original plan, in order to ensure swift access to the domestic population.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.